Last edition
News about
Santhera Partners with Ikris Pharma Network for Distribution of AGAMREE in India
Swiss specialty pharma company Santhera Pharmaceuticals has entered into an exclusive agreement with Ikris Pharma Network to distribute AGAMREE (vamorolone) in India for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above.
Aptamer Group Launces Novel Biomarker Discovery Service
Aptamer Group, a UK-based developer of next-generation synthetic binders, has launched a new biomarker discovery service, providing researchers in pharmaceuticals, biotechnology, and diagnostics with an innovative solution for identifying and validating novel disease markers.<br />
Prometheus Laboratories Collaborates with Celltrion for Anser Testing
Prometheus is the first specialty lab to validate TDM testing for both intravenous and subcutaneous infliximab, supporting the growing demand for at-home treatment options.
SwRI Scientists Develop Ion-Assisted Chromatography Process to Accelerate Drug Development
Scientists at Southwest Research Institute have accidently made a discovery of an ion-assisted chromatography process to accelerate drug development.
Bio-Thera and Gedeon Richter Secure EC Approval for Usymro, a Stelara Biosimilar
Bio-Thera Solutions Inc., a commercial-stage biopharmaceutical company, announced that the European Commission (EC) has approved BAT2206 (ustekinumab), a biosimilar referencing Janssen’s Stelara, following a positive opinion from the EMA’s CHMP on June 19, 2025. The product will be marketed in Europe by Gedeon Richter under the brand name Usymro.
TCS Partners with Unilab to Drive Cloud-Led Digital Transformation in the Philippines Pharma Sector
Tata Consultancy Services (TCS) has entered into a strategic partnership with Unilab, Inc., one of the Philippines’ largest pharmaceutical and healthcare companies, to modernise its core business systems through a comprehensive cloud migration initiative.
FDA Approves Updated COVID-19 Vaccines with New Access Restrictions for Children and Adults
While seniors retain full access, younger adults and children will now need to demonstrate at least one high-risk health condition—such as asthma or obesity—to qualify for vaccination, significantly narrowing eligibility.
MS Pharma Sets Up MENA's First Biologics Manufacturing Hub in Saudi Arabia
MS Pharma has inaugurated the Middle East’s first biologics manufacturing facility in Saudi Arabia, a USD 50 million GMP-approved plant that establishes the company as a regional hub for advanced biopharmaceutical production aligned with Vision 2030.
Esaote North America and Epica International Partner to Expand MRI and CT Imaging Market Reach
Esaote North America has entered into a strategic partnership with Epica International to expand market presence and accelerate the adoption of high-performance MRI and CT solutions across the human and veterinary healthcare sectors.
Neusoft Medical Systems Secures NMPA Approval for China's First Photon-Counting CT
Neusoft Medical Systems has announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Products Administration (NMPA).
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy